← Leaderboards
Robert B Stewart
Abiomed, Inc.
$1,774,891
Attributed
$1,774,891
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $416.6K · FY2006–07$500K$375K$250K$125K$0
'06
'07
Funding mix
By agency
NIH$1,774,891 · 5
By mechanism
R44$1,475,529 · 2
R43$299,362 · 3
Top collaborators
No co-investigators on record.
Most similar at Abiomed, Inc.
Same institution · by research overlap
- Robert T Kung$728,624
- Robert T.v. Kung$81,573
Others in their field
Top investigators on “Biotechnology”
- David Heimbrook · Leidos Biomedical Research, Inc.$140,255,767
- Larry Arthur$82,860,406
- Jaap Goudsmit · Beth Israel Deaconess Medical Center$53,211,858
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$51,699,453
- Richard A Gibbs · Baylor College Of Medicine$51,685,612
- Garret A Fitzgerald · University Of Pennsylvania$50,415,853
Research focus
BiotechnologyBiomaterial Development /PreparationAntithrombogenic SurfaceLasersTissue EngineeringMedical Implant SciencePolymersImplantMicrocirculationMyocardiumCirculatory AssistLaboratory RatMicrosurgeryBiomaterial CompatibilitySurgery Material /EquipmentAuxiliary Heart ProsthesisHeart FailureHeatBiosensor DeviceBiomedical Equipment DevelopmentAssistive Device /TechnologyChildhoodBiomaterial EvaluationAnimal Model
Grant awards (7)
An Artificial Myocardium for Pediatric Support$379,724
R44 · FY2007 · HL · contact PI
An Artificial Myocardium for Pediatric Support$416,551
R44 · FY2006 · HL · contact PI
A Smart Polymer for Destination Cardiac Assist Devices$99,837
R43 · FY2004 · HL
A Bioactive Polymer Designed for Cardiac Assist Devices$99,978
R43 · FY2003 · HL
An Artificial Myocardium for Pediatric Support$99,547
R43 · FY2003 · HL
ANTITHROMBOTIC TISSUE SOLDERS FOR MICROVASCULAR REPAIRS$361,042
R44 · FY2001 · HL
ANTITHROMBOTIC TISSUE SOLDERS FOR MICROVASCULAR REPAIRS$318,212
R44 · FY2000 · HL